WiSEED

Founded in 2008, WiSEED is a French crowdfunding platform that connects investors with SMEs and enterprises seeking funding. It offers investment opportunities across various sectors including startups, real estate, social innovation, renewable energy, and agriculture.

Thierry MERQUIOL

Co-Founder and Chairman of the board

Nicolas SÉRÈS

Co-Founder and CEO

30 past transactions

BiPER Therapeutics

Debt Financing in 2024
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutic solutions. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to overcome treatment resistance and enhance cancer cell survival. Their primary focus is on providing effective treatments for gastrointestinal cancers.

Vaxinano

Venture Round in 2024
Vaxinano is a biotechnology company founded in 2016, focused on the preclinical and pharmaceutical development of vaccines and drug delivery systems for both humans and animals. Building on 25 years of research and clinical trials led by Pr Didier Betbeder, Vaxinano specializes in creating prophylactic and therapeutic vaccines for infectious diseases. The company employs safe-by-design nanoparticles that adhere to green chemistry principles, facilitating the development of drugs targeting active biomolecules, proteins, and antigens. This innovative approach enables medical researchers to create new vaccines aimed at addressing untreated viral, bacterial, and parasitic diseases.

BiPER Therapeutics

Seed Round in 2023
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutic solutions. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to overcome treatment resistance and enhance cancer cell survival. Their primary focus is on providing effective treatments for gastrointestinal cancers.

Dianosic

Seed Round in 2023
Founded in 2017, Dianosic specializes in developing innovative medical devices for Ear, Nose, and Throat (ENT) conditions. The company's flagship product is the Active Resorbable Intranasal Scaffold (ARIS), a long-acting, patient-friendly device designed to treat chronic rhinitis and sinusitis, offering an alternative to daily medication.

VistaCare Medical

Venture Round in 2022
VistaCare Medical is a French company specializing in the development, manufacturing, and distribution of innovative medical devices designed to treat acute and chronic wounds. The company focuses on non-contact wound treatment within a controlled environment, which enhances patient care and significantly reduces treatment times and hospital stays. VistaCare's technology aims to improve the quality of life for patients suffering from complex wounds and provides caregivers with tools to simplify their daily tasks. By addressing critical therapeutic needs, such as isolating nosocomial risks and enabling visual monitoring of wound progression, VistaCare facilitates personalized care tailored to the specific type and stage of each wound, ultimately advancing the standard of wound management.

BioIntrant

Venture Round in 2022
BioIntrant develops and provides solutions to improve agricultural productivity through biotechnology and related disciplines. The company offers services and products spanning agriculture, agronomy, microbiology, bioinformatics, genomics, biostimulation, and other biotechnology applications, with a focus on enhancing plant health. It develops biofertilizers designed to work within the plant’s environment to bolster natural defenses, supporting farmers in achieving higher productivity in an environmentally responsible manner.

Spartha Medical

Seed Round in 2021
Spartha Medical is a medical technology company focused on developing innovative coatings designed to enhance the safety of medical devices and consumer products. The company utilizes eco-friendly and biocompatible coatings made from natural biopolymers, which possess antibacterial, antiviral, and anti-inflammatory properties. Their patented technology allows for precise control over the assembly of two distinct polyelectrolytes, enabling the creation of versatile and multifunctional surface coatings tailored to specific applications. By providing effective solutions that protect users from microbial and inflammatory risks, Spartha Medical aims to improve healthcare outcomes and promote safer use of medical devices across various healthcare settings.

WattPark

Seed Round in 2021
WattPark provides a charging point solution for the automobile industry, offering reservable and monetizable charging stations that can be booked and controlled via a mobile application. The platform enables users to select precise locations and access related services through Bluetooth, and it supports charging tools and parking devices that operate in areas with limited or no network coverage. WattPark's solution targets automobile clients seeking flexible, location-based charging and parking options, delivering a streamlined user experience through a bookable point system.

uvoji by T.zic

Seed Round in 2020
uvoji designs, develops, manufactures and markets all-in-one solutions for the treatment and disinfection of water at points of use and of surfaces by UV LEDs. To meet the major challenges of access to drinking water and provide technological solutions to the urgent needs of point-of-use water treatment, we launched the Oji Safe, Oji Pure and Oji Reuse products. Our solutions are used notably by the French Red Cross for its operations. In response to the Covid pandemic, we developed the Uvo Care. Uvo Care is the disinfection box, Made in France, for all types of masks and everyday objects. The essential ally for resuming your professional activities in complete safety. It has been tested and approved by independent laboratories and kills over 99.999% of viruses and bacteria in just seconds (including SARS-COV2 virus).

Lumi'In

Venture Round in 2019
Lumi'In is a manufacturer and distributor of smart solar streetlights based in Malijai, France. Established in 2014, the company specializes in designing and assembling innovative solar lighting systems, including models such as Frisbi, Caraibe, Astral, Classic, Wave, Galaxy, HCPL, and New Classic/New Style. Lumi'In's products utilize photovoltaic technology to produce electric energy, which is stored in batteries for nighttime use, offering a cleaner alternative to traditional lighting solutions. In addition to its diverse range of streetlights, the company provides smart charge regulators and various customer services, including on-site visits, brightness simulations, product customization, and power-tuning services.

gulplug

Equity Crowdfunding in 2019
Gulplug designs and develops technologies that connect electrical systems to power grids and the Internet, delivering an end-to-end e-mobility solution that includes E-Cube wireless energy sensors, E-Case, a plug-and-play suitcase that operates independently and captures consumption data, and SELFPLUG, a rechargeable EV socket, along with a Cleantech Save It Yourself online platform for monitoring machine energy use. Founded in 2014 and based in Grenoble, France, Gulplug provides a universal, secure, and cost-effective plug-in technology that eliminates the need for a wallbox, enabling electric vehicle charging in public and private spaces with reduced costs and enhanced convenience. Its products feature a safe magnetic hold and water resistance, leverage Internet of Things connectivity, and support energy efficiency. The company also offers co-innovation services to tailor its solutions to customer needs.

Lattice Medical

Seed Round in 2018
Lattice Medical is a French medical device company focused on breast reconstruction after cancer. It designs and manufactures implantable devices that promote regeneration of autologous adipose tissue to enable natural breast reconstruction following mastectomy. The flagship implant, MATTISSE, uses 3D printing and fully biodegradable materials to provide personalized reconstruction in a single surgery, reducing operative time and invasiveness. The company aims to offer an alternative to silicone-based implants by supporting tissue regeneration rather than replacement. Founded in 2017 and based in Loos, France, Lattice Medical develops solutions to address clinical and societal needs by restoring form and function for women recovering from breast cancer.

ffly4u

Venture Round in 2018
ffly4u SAS provides innovative solutions for tracking reusable mobile assets and transport packaging, specializing in low-frequency locating services. Founded in 2014 and based in Toulouse, France, the company offers several applications, including myDrum, myBin, myTrailer, and myEquipment, which facilitate both outdoor and indoor geolocation of various assets. These solutions cater to a wide range of industries, such as telecommunications, waste management, construction, and agriculture, by serving logistics and supply chain managers, as well as financial and operational executives. The technology combines a device for asset attachment, low-power wide-area network (LPWAN) connectivity for data transmission, and a data platform powered by ThingWorx for effective data management. This comprehensive approach positions ffly4u as a leader in embedded information for B2B mobile assets in Europe.

Virage-Viager

Venture Round in 2018
Virage-Viager, founded in 2010 and based in Paris, France, specializes in providing life insurance solutions tailored for senior citizens. The company focuses on fostering intergenerational savings, enabling seniors to maintain financial stability and quality of life as they age. Through its innovative approach, Virage-Viager aims to address the financial needs of older adults while promoting equity and support within families.

Levels3D

Series A in 2018
Levels3D is a French startup founded in 2012 by Yannick Folliard, specializing in 3D and augmented reality solutions. The company develops an innovative 3D scanning application compatible with next-generation tablets and smartphones that feature depth sensors. This application is tailored for professionals in consulting, architecture, general contracting, and space design, enabling them to manage and utilize 3D scans effectively. Additionally, Levels3D offers MyCaptR, a 3D scanning solution designed for professionals, alongside Smart Glasses-ERDF, a prototype augmented reality device that enhances the user experience. Through its advanced technology, Levels3D aims to transform how industries visualize and interact with spatial designs.

Pili

Venture Round in 2018
PILI Inc. is a biotechnology company based in Paris, France, that specializes in the research and manufacturing of bio-fabricated colors using microorganisms. Founded in 2012, the company focuses on developing enzymes and fermentation biotechnologies that transform sugar into renewable and durable dyes and pigments. By offering a sustainable alternative to traditional toxic and non-recyclable inks, PILI aims to replace petrochemical and vegetable-based colorants with organic dyes produced at an industrial scale. The company's innovative approach not only promotes sustainable development but also enables businesses to reduce costs while utilizing environmentally friendly materials.

Poietis

Series A in 2018
Poietis is a biotechnology company focused on regenerative medicine therapies through 4D laser bioprinting. It offers a platform that enables researchers and industrial partners to design and manufacture bio-printed tissues for regenerative medicine, preclinical research, and evaluation of cosmetic ingredients. The company is developing 3D physiological tissue models to provide more predictive in vitro assessments of drug toxicity and efficacy. It collaborates with international pharmaceutical and cosmetic groups on complex bio-printed products, including a hair follicle bioprinting project with L'Oréal. Poietis has developed a single-cell bioprinting platform to align tissue printing with industrial production and manufacturing standards for clinical products. Its work supports personalized medicine by advancing tissue engineering capabilities and offering versatile options in biomaterials and hydrogels for research and development.

1Check

Venture Round in 2017
1Check is a SaaS platform and mobile application established in 2012, dedicated to enhancing operations management within the hospitality sector. The company provides a specialized solution tailored to the unique requirements of housekeeping, maintenance, and management teams. With a presence in over 350 client sites across Europe, 1Check has garnered recognition as a leader in its field. The platform enables managers to efficiently create and organize schedules for cleaning and maintenance teams, thereby improving customer service quality and boosting team productivity. By offering intuitive technology, 1Check aims to enhance customer satisfaction, reduce staff movement, and improve working conditions for employees in the hospitality industry.

Vectalys

Venture Round in 2016
Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technology to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.

SUNiBrain

Venture Round in 2016
SUNiBrain specializes in enhancing photovoltaic cell performance through its patented rainwater cooling system. This durable solution maintains optimal panel temperature, ensuring maximum efficiency year-round while reducing maintenance costs.

Algo Paint

Equity Crowdfunding in 2016
Algo Paint is a French manufacturer of algae-based paints and coatings based in Vern-sur-Seiche, France. The company uses algae as the raw material for its coatings, providing products for interior and exterior applications with health-focused and ecological qualities. It aims to replace fossil-fuel-based finishes by using renewable local resources, offering an environmentally safer alternative that aligns with environmental standards in multiple regions and supports sustainable building practices.

StayHome SAS

Seed Round in 2016
StayHome SAS operates a real estate portage platform that supports private individuals in executing rental investments while providing assistance to property owners facing financial difficulties. The platform enables owners to temporarily sell their real estate to raise capital for debt management. Importantly, it allows these owners to remain tenants in their properties, with an agreement to repurchase the property at a predetermined price within a specified timeframe. The company’s solutions are designed to be accessible, offering flexible financing without age, health, or income criteria, catering to private and professional owners who may not qualify for traditional bank financing. Through this approach, StayHome facilitates affordable housing options for its users.

Poietis

Equity Crowdfunding in 2016
Poietis is a biotechnology company focused on regenerative medicine therapies through 4D laser bioprinting. It offers a platform that enables researchers and industrial partners to design and manufacture bio-printed tissues for regenerative medicine, preclinical research, and evaluation of cosmetic ingredients. The company is developing 3D physiological tissue models to provide more predictive in vitro assessments of drug toxicity and efficacy. It collaborates with international pharmaceutical and cosmetic groups on complex bio-printed products, including a hair follicle bioprinting project with L'Oréal. Poietis has developed a single-cell bioprinting platform to align tissue printing with industrial production and manufacturing standards for clinical products. Its work supports personalized medicine by advancing tissue engineering capabilities and offering versatile options in biomaterials and hydrogels for research and development.

Naïo Technologies

Seed Round in 2015
Founded in 2011, Naïo Technologies designs and develops electric tools for mechanical weeding and harvesting in agriculture. Headquartered in Midi-Pyrénées, France, the company specializes in improving farming efficiency while reducing chemical usage.

GAIDDON

Seed Round in 2015
Founded in 2010 by 4 entrepreneurs, GAIDDON Software SAS is a simplified joint-stock company registered under French law with a share capital of 161,100 Euros. It is based in Toulouse, south of France. GAIDDON Software is integrated within the Toulouse Metropole business incubator since its creation. In 2011, the company gained the french label “Jeune Entreprise Innovante” from the ministry of higher education and research. It indicates that most of the work done by the company is an innovative research and development. This innovative work is our 3D environment builder technology from aerial/satellite imagery.

MyFeelBack

Venture Round in 2014
MyFeelBack is a developer of an innovative online customer survey and feedback platform that enables businesses to gather valuable insights about their customers. The platform allows companies to continuously update their customer databases and collect high-quality feedback, which facilitates data-driven decision-making. By asking targeted questions and displaying relevant messages to users based on their behavior, MyFeelBack empowers businesses to understand their customers deeply. This capability helps organizations identify areas for improvement, spot emerging trends, and implement personalized marketing strategies, ultimately driving sales conversion and enhancing growth.

Antabio

Seed Round in 2012
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Intuiface

Seed Round in 2011
Intuiface is a no-code platform that specializes in creating, integrating, deploying, and analyzing interactive digital experiences for physical spaces. Serving over 1,600 companies in more than 70 countries, it enables organizations across various industries, including retail, hospitality, real estate, tourism, and education, to engage audiences through interactive technologies. The platform supports diverse options such as touch, RFID/NFC, computer vision, and Internet of Things integration, allowing businesses to build and measure tactile digital experiences on a range of devices, from tablets to kiosks and video walls, without any programming expertise. Intuiface is also ISO 27001 Certified, ensuring a high standard of security for its users.

Antabio

Seed Round in 2011
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Noomeo

Venture Round in 2009
Noomeo is a pioneering company established in 2007, focused on providing innovative 3D scanning solutions for businesses seeking user-friendly and portable systems. The company specializes in non-contact 3D digitization, enabling companies to integrate this technology into their processes efficiently and cost-effectively. Noomeo's commitment to research and development, in collaboration with esteemed research institutions, allows it to continually enhance its offerings. The company has developed advanced hardware solutions, known as OptiNum, and accompanying software, called NumiSoft, which automate the creation of 3D mock-ups. Through these innovations, Noomeo positions itself as a leader in the field of 3D digitization, catering to the evolving needs of various industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.